Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2017 May 25;154(5):1756–1762. doi: 10.1016/j.jtcvs.2017.05.065

TABLE 1.

Demographics for all patients enrolled in the study

TAV
BAV
NA TAA NA TAA
n, M/F 27 (20/6)* 28 (18/10) 22 (15/7) 53 (43/10)

Age, y 59.5 ± 16 64.0 ± 10 56 ± 14 56 ± 11

Diameter, mm    ≤42 52.0 ± 5.2 38 ± 4.28, 49.0 ± 4.3,§

Aortic index     ≤2.20 2.60 ± 0.52 1.82 ± 0.27, 2.34 ± 0.38,§

HTN  67% 79% 68% 71%

Smoking  83% 67% 57% 55%

AI
 1+    6% 26% 29% 26%
 2-3+  25% 30% 10% 14%
 4+    6% 15% 19% 12%

AS
 Mild    0% 0% 0% 8%
 Mod    0% 0% 5% 16%
 Severe  15% 9% 71 %, 49%,

Data are expressed as median ± SD (age and diameter), or as percentage (HTN, smoking, AI, and AS). TAV, Tricuspid aortic valve; BAV, bicuspid aortic valve; NA, nonaneurysmal; TAA, thoracic aortic aneurysm; n, number of patients enrolled; M, male; F, female; HTN, hypertension; AI, aortic insufficiency; AS, aortic stenosis; Mod, moderate.

*

The sex of 1 patient was unknown.

†, §, ‖

Indicate P < .05 versus TAV-TAA, BAV-NA, and TAV-NA, respectively, as assessed by χ2 test or a MannWhitney U test.

The diameter of 7 patients was unknown.